Fresh analysis reveals that people who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain lost weight much more quickly than those who halt conventional diet and exercise regimens.
Research printed in a leading medical journal shows that while obese individuals often shed substantial amounts of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month once they quit.
"Individuals using such treatments must be aware of the risk of rapid weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.
Such speed of recovery implies a return to original weight in about one and a half years.
Analyzing Approaches
The analysis, which reviewed 37 of studies involving thousands of participants, contrasted the effects of GLP-1 agonists with conventional dieting.
Scientists point out that individuals who lose weight through diet and exercise usually have a slower weight regain—around 100 grams monthly—once they finish.
Explaining the Rapid Regain
Doctors suggest the way of the drugs accounts for the accelerated weight return.
These medications copy a body's own chemical called GLP-1, which helps regulate appetite.
"Long-term administration of GLP-1 concentrations far above than the body's typical production might result in the system to produce less of its own natural GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' means appetite is unsuppressed, making overeating far more likely."
A Chronic Issue?
Health authorities recommend the injections for people with obesity-related health risks, alongside prescribed lifestyle changes.
Many experts argue that, considering the significant potential of weight regain, the therapy should be considered life-long.
This opinion is reinforced by pharmaceutical companies, who state that the results "highlight the chronic nature of obesity," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have come off the jabs describe a powerful return of cravings.
"It was like a switch flipping and you're instantly extremely hungry," said an individual.
This difficulty is exacerbated if patients have not developed permanent lifestyle or habit changes during therapy.
Significant Adoption
Figures indicate that millions of adults in the UK have used these injections in the past year, with desire continuing to grow.
- Adoption is higher among females compared to men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone fix and lasting health benefits relies on combined lifestyle changes.